Why Cue Health Blasted Higher Today
Monday was a very good day for stocks in general, but it was a standout day for healthcare diagnostics specialist Cue Health (NASDAQ: HLTH). In retrospect, the stock's nearly 22% leap wasn't surprising, as the current state of the world plays perfectly to the company's strength.
On its website, Cue Health isn't shy to point out that it's the maker of the first molecular diagnostic test for COVID-19 approved by the U.S. Food and Drug Administration (FDA). So as far as coronavirus testing goes, the company was a first mover, with a product that is relatively better established than others. Cue Health's COVID diagnostic test is also a product that can be administered at home with no training.
Image source: Getty Images.
Source Fool.com
